Kazunori Hosoe

This inventor holds 20 USPTO granted patents and 3 published patent applications, plus 16 CIPO patents and 11 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Kaneka Corporation, Kanegafuchi Kagaku Kogyo Kabushiki Kaisha, Kanegafuchi Chemical Industry Co., Ltd.. Active years: 1984-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazunori Hosoe. Retrieved from https://idiyas.com/inventor/kazunori-hosoe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 16 (Patent Applications = 2)

EPO Patents = 11 (Patent Applications = 1)

Average Co-Inventor Count = 5.5

ph-index = 9

Forward Citations = 203(Granted Patents)

Location History:

Hyogo, JP (2013)
Takasago, JP (1984 - 2015)

Company Filing History:

Kanegafuchi Kagaku Kogyo Kabushiki Kaisha

patents

2 out of 109

Kanegafuchi Chemical Industry Co., Ltd.

patents

Years Active: 1984-2015

Loading Chart...

Areas of Expertise:

Fatigue Reducing Agent

Transmucosal Administration

Coenzyme Q

Oxidative Stress

Arteriosclerosis

Rifamycin Derivative

Antibacterial Compositions

Chlamydia Treatment

Tyrosine Kinase Inhibitors

Anti-inflammatory Composition

Digestive Diseases

Pharmaceutical Composition

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8946303 - Fatigue reducing agent (2015-02-03),

2. 8562975 - [object Object] (2013-10-22),

3. 7829080 - [object Object] (2010-11-09),

4. 7754205 - Composition for transmucosal administration containing conenzyme Q as the active ingredient (2010-07-13),

5. 7364751 - Stabilized compositions of aqueous reduced coenzyme Q solution (2008-04-29),

6. 7015252 - Compositions for lessening oxidative stress (2006-03-21),

7. 6939897 - Method and composition for inhibiting arteriosclerosis (2005-09-06),

8. 6486161 - Use of rifamycin derivative for treating mastitis in a domestic animal (2002-11-26),

9. 6362169 - Antibacterial compositions with synergistic effect, drugs and remedies for digestive diseases containing the same, process for the production thereof and preparations associated therewith (2002-03-26),

10. 5981522 - Treatment of disease caused by infection of Helicobacter (1999-11-09),

11. 5786349 - Method for treating chlamydia infectious diseases by rifamycin derivative (1998-07-28),

12. 5202341 - Hydroxystyrene compounds having tyrosine kinase inhibiting activity (1993-04-13),

13. 5089516 - 1-phenyl-3,5-pyrazolidinedione hydroxystyrene compounds which have (1992-02-18),

14. 4983602 - 3'-hydroxybenzoxazinorifamycin derivative, process for preparing the (1991-01-08),

15. 4971996 - Hydroxystyrene compounds which are useful as tyrosine kinase inhibitors (1990-11-20),

Title: **Innovative Contributions of Kazunori Hosoe in the Field of Health Supplements**

Introduction

Kazunori Hosoe, an esteemed inventor based in Takasago, Japan, has made significant strides in the field of health and wellness through his innovative patents. With a remarkable portfolio of 20 patents, Hosoe’s work primarily focuses on enhancing physical fitness and health, particularly for middle-aged and older individuals in an aging society.

Latest Patents

One of Hosoe's latest inventions is a fatigue reducing agent designed to maintain the health and fitness of middle-aged and older persons. This agent is formulated from a composition of highly safe substances, enabling long-term administration to prevent and mitigate fatigue, including muscle fatigue. Notably, the composition containing reduced coenzyme Q has shown efficacy not only in young subjects but is especially pronounced in aged rats, demonstrating its potential benefits for various age groups.

Another recent patent relates to a method for stabilizing reduced coenzyme Q, which has significant implications for good foods, functional nutritional products, and health supplements. This innovative composition consists of reduced coenzyme Q, combined with fats, oils (excluding olive oil), and/or polyols, ensuring effective stabilization. This stability allows for versatility across numerous applications, including cosmetics and medicinal products.

Career Highlights

Throughout his career, Kazunori Hosoe has collaborated with prominent organizations, notably Kaneka Corporation and Kanegafuchi Kagaku Kogyo Co., Ltd. His extensive work in these companies has positioned him as a key contributor to advancements in the health supplement industry.

Collaborations

Hosoe has worked alongside notable colleagues such as Takayoshi Hidaka and Kiyoshi Watanabe. These collaborations have further enriched the innovation landscape, allowing for the development of cutting-edge solutions that address health and wellness challenges.

Conclusion

Kazunori Hosoe's innovative contributions and dedication to improving health through his inventions highlight the potential of scientific advancements in enhancing the quality of life for individuals in an aging society. His work continues to inspire future innovations in the health sector, paving the way for further research and development in effective health supplements.

Profile summary based on public USPTO records.